Insider filing · BGNE
Xiaodong Wang sold $9.3M of BeiGene (BGNE)
Executed May 13 2025, disclosed May 15 2025, 2 days later.
Value, as filed
$9.3M
41,560 sh across 3 lots
Executed
May 13 2025
the trade date, as filed
Disclosed
May 15 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
XW
Xiaodong Wang
Director
profile →
Xiaodong Wang (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in BGNE. The largest single filing was $13.4M of ONC (38,287 sh across 8 lots, as filed), executed Sep 8.
The name
BGNE
BGNE
BGNE · 23 filings in 24 months
ticker →
Insider filings, newest first→
View the original filing at www.sec.gov→
Other filings by Xiaodong Wang in BGNE
BGNESALE
BeiGene, Ltd.
$10.0M41,395 sh across 12 lots
Exec Apr 14 2025
Filed Apr 16 2025 · 5:30 PM ET BGNESALE BeiGene, Ltd. $10.9M
41,760 sh across 7 lots
Exec Mar 18 2025
Filed Mar 20 2025 · 5:30 PM ET BGNESALE BeiGene, Ltd. $2.0M
7,823 sh across 6 lots
Exec Mar 4 2025
Filed Mar 6 2025 · 5:30 PM ET BGNESALE BeiGene, Ltd. $9.4M
41,760 sh across 6 lots
Exec Feb 4 2025
Filed Feb 6 2025 · 5:30 PM ET BGNESALE BeiGene, Ltd. $7.4M
41,760 sh across 5 lots
Exec Jan 7 2025
Filed Jan 8 2025 · 5:30 PM ET BGNESALE BeiGene, Ltd. $7.7M
41,460 sh across 10 lots
Exec Dec 10 2024
Filed Dec 12 2024 · 5:30 PM ET BGNESALE BeiGene, Ltd. $8.9M
47,044 sh across 13 lots
Exec Nov 26 2024
Filed Nov 29 2024 · 5:30 PM ET